Results 321 to 330 of about 200,052 (360)

Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection

International Journal of Stroke, 2019
Background Intravenous thrombolysis with alteplase within a time window up to 4.5 h is the only approved pharmacological treatment for acute ischemic stroke.
P. Ringleb, M. Bendszus, E. Bluhmki, G. Donnan, C. Eschenfelder, M. Fatar, C. Kessler, C. Molina, D. Leys, G. Muddegowda, S. Poli, P. Schellinger, S. Schwab, J. Serena, D. Toni, N. Wahlgren, W. Hacke   +16 more
semanticscholar   +1 more source

Ultrasound Thrombolysis

Thrombosis and Haemostasis, 1999
SummaryThe possibility of lysing clots by the direct intravascular application of ultrasound was described first in 1974 in an animal experiment. However research on therapeutic ultrasound for thrombolysis gained momentum in the early 1980s and is now divided into several directions: 1) pharmacological thrombolysis supported by externally applied ...
openaire   +2 more sources

Decreased clot debris size and increased efficiency of acoustic vortex assisted high intensity focused ultrasound thrombolysis

, 2020
High intensity focused ultrasound (HIFU) thrombolysis is a non-pharmacological, non-invasive treatment option for the restoration of blood flow through occluded vessels.
Shifang Guo, Xin Wang, Xuyan Guo, Zhen Ya, Pengying Wu, A. Bouakaz, M. Wan   +6 more
semanticscholar   +1 more source

Thrombolysis for acute ischaemic stroke: current status and future perspectives

Lancet Neurology, 2023
G. Tsivgoulis, A. Katsanos, E. Sandset, G. Turc, Thanh N. Nguyen, A. Bivard, U. Fischer, P. Khatri   +7 more
semanticscholar   +1 more source

[Other indications of thrombolysis: thrombolysis in the elderly, late thrombolysis].

Archives des maladies du coeur et des vaisseaux, 1992
Thrombolytic therapy has been shown to preserve left ventricular function and reduce mortality in the acute phase of myocardial infarction. When the usual inclusion criteria are respected, only about 30% of patients can benefit from this form of treatment. The "excluded" cases are more numerous and have a worse prognosis.
A, Vahanian, O, Nallet, J P, Maroni, J, Acar   +3 more
openaire   +1 more source

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

Journal of the American Medical Association (JAMA), 1995
W. Hacke, M. Kaste, C. Fieschi, D. Toni, E. Lesaffre, R. von Kummer, G. Boysen, E. Bluhmki, G. Höxter, M. Mahagne   +9 more
semanticscholar   +1 more source

Intravenous Thrombolysis

International Journal of Stroke, 2010
Thang H, Nguyen, Anh T L, Truong, Minh Ba, Ngo, Chau T Q, Bui, Quang V, Dinh, Tan C, Doan, Lien T K, Nguyen, Tan C, Phan, Mung V, Phan, Tuan V, Nguyen, Thanh V, Le   +10 more
openaire   +2 more sources

Coronary Thrombolysis

Chest, 1992
J A, Cairns, V, Fuster, J W, Kennedy
openaire   +3 more sources

ARTERIAL THROMBOLYSIS

The Lancet, 1971
C N, Chesterman, A A, Sharp
openaire   +2 more sources

Venous thrombolysis

European Journal of Vascular Surgery, 1988
D J, Scott, W, Farmilo, M, Horrocks, P, Taylor   +3 more
openaire   +2 more sources